Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5DVA

Fragments bound to the OXA-48 beta-lactamase: Compound 1

5DVA の概要
エントリーDOI10.2210/pdb5dva/pdb
関連するPDBエントリー4s2p
分子名称Beta-lactamase, 3-(pyridin-4-yl)benzoic acid, CHLORIDE ION, ... (4 entities in total)
機能のキーワードhydrolase, inhibitor, complex, fragment, lactamase
由来する生物種Klebsiella pneumoniae
タンパク質・核酸の鎖数4
化学式量合計114059.84
構造登録者
Lund, B.A.,Christopeit, T.,Leiros, H.-K.S. (登録日: 2015-09-21, 公開日: 2016-06-01, 最終更新日: 2024-01-10)
主引用文献Lund, B.A.,Christopeit, T.,Guttormsen, Y.,Bayer, A.,Leiros, H.K.
Screening and Design of Inhibitor Scaffolds for the Antibiotic Resistance Oxacillinase-48 (OXA-48) through Surface Plasmon Resonance Screening.
J.Med.Chem., 59:5542-5554, 2016
Cited by
PubMed Abstract: The spread of antibiotic resistant bacteria is a global threat that shakes the foundations of modern healthcare. β-Lactamases are enzymes that confer resistance to β-lactam antibiotics in bacteria, and there is a critical need for new inhibitors of these enzymes for combination therapy together with an antibiotic. With this in mind, we have screened a library of 490 fragments to identify starting points for the development of new inhibitors of the class D β-lactamase oxacillinase-48 (OXA-48) through surface plasmon resonance (SPR), dose-rate inhibition assays, and X-ray crystallography. Furthermore, we have uncovered structure-activity relationships and used alternate conformations from a crystallographic structure to grow a fragment into a more potent compound with a KD of 50 μM and an IC50 of 18 μM.
PubMed: 27165692
DOI: 10.1021/acs.jmedchem.6b00660
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.50003891197 Å)
構造検証レポート
Validation report summary of 5dva
検証レポート(詳細版)ダウンロードをダウンロード

226707

件を2024-10-30に公開中

PDB statisticsPDBj update infoContact PDBjnumon